Celltrion JV Co created for commercialisation of Remsima®, Truxima® and Herzuma®

Jul 18, 2019

Celltrion announces creation of a JV Co with Nan Fung Group for the commercialisation of Remsima®, Truxima® and Herzuma® in China. The new company Vcell Healthcare will obtain exclusive rights to develop, manufacture and commercialise these three products in mainland China.

Print Page Mail Article